D
Daniel Cohen
Researcher at Royal Free London NHS Foundation Trust
Publications - 33
Citations - 4053
Daniel Cohen is an academic researcher from Royal Free London NHS Foundation Trust. The author has contributed to research in topics: Bladder cancer & Cancer. The author has an hindex of 13, co-authored 26 publications receiving 2758 citations. Previous affiliations of Daniel Cohen include European Association of Urology & University of Hertfordshire.
Papers
More filters
Journal ArticleDOI
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.
Marko Babjuk,Andreas Böhle,Maximilian Burger,Otakar Čapoun,Daniel Cohen,Daniel Cohen,Eva Comperat,Virginia Hernández,Eero Kaasinen,Joan Palou,Morgan Rouprêt,Bas W.G. van Rhijn,Shahrokh F. Shariat,Viktor Soukup,Richard Sylvester,Richard Zigeuner +15 more
TL;DR: These abridged EAU guidelines present updated information on the diagnosis and treatment of NMIBC for incorporation into clinical practice and the stratification of patients into low-, intermediate-, and high-risk groups is pivotal to recommending adjuvant treatment.
Journal ArticleDOI
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update.
Marko Babjuk,Marko Babjuk,Maximilian Burger,Eva Comperat,Paolo Gontero,A. Hugh Mostafid,Joan Palou,Bas W.G. van Rhijn,Bas W.G. van Rhijn,Morgan Rouprêt,Shahrokh F. Shariat,Richard Sylvester,Richard Zigeuner,Otakar Čapoun,Daniel Cohen,José Luis Dominguez Escrig,Virginia Hernández,Benoit Peyronnet,Thomas Seisen,Viktor Soukup +19 more
TL;DR: The European Association of Urology Non-muscle-invasive Bladder Cancer (NMIBC) Panel has released an updated version of their guidelines, which contains information on classification, risk factors, diagnosis, prognostic factors, and treatment of NMIBC.
Journal ArticleDOI
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ).
Marko Babjuk,Marko Babjuk,Maximilian Burger,Otakar Čapoun,Daniel Cohen,Eva Compérat,José Luis Dominguez Escrig,Paolo Gontero,Fredrik Liedberg,Alexandra Masson-Lecomte,A. Hugh Mostafid,Joan Palou,Bas W.G. van Rhijn,Bas W.G. van Rhijn,Morgan Rouprêt,Shahrokh F. Shariat,Shahrokh F. Shariat,Thomas Seisen,Viktor Soukup,Richard Sylvester +19 more
TL;DR: The European Association of Urology (EAU) has released an updated version of the guidelines on non-muscle-invasive bladder cancer (NMIBC).
Journal ArticleDOI
Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non–muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review
Viktor Soukup,Otakar Čapoun,Daniel Cohen,Virginia Hernández,Marek Babjuk,Max Bürger,Eva Comperat,Paolo Gontero,Thomas B. Lam,Steven MacLennan,A. Hugh Mostafid,Joan Palou,Bas W.G. van Rhijn,Morgan Rouprêt,Shahrokh F. Shariat,Richard Sylvester,Yuhong Yuan,Richard Zigeuner +17 more
TL;DR: Current grading classifications in NMIBC are suboptimal; both systems predict progression and recurrence, although pathologists vary in their reporting; suggestions for further improvements are made.
Journal ArticleDOI
European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel.
Richard Sylvester,Oscar Rodríguez,Virginia Hernández,Diana Turturica,Lenka Bauerová,Harman Max Bruins,Harman Max Bruins,Johannes Bründl,Theo van der Kwast,Antonin Brisuda,José Rubio-Briones,Maximilian Seles,Anouk E. Hentschel,Anouk E. Hentschel,Venkata R.M. Kusuma,Nicolai A. Huebner,Juliette Cotte,Laura S. Mertens,Dimitrios Volanis,Olivier Cussenot,Jose D. Subiela Henríquez,Enrique de la Peña,Francesca Pisano,Francesca Pisano,Michael Pešl,Antoine G. van der Heijden,Sonja Herdegen,Alexandre R. Zlotta,Jaromir Hacek,Ana Calatrava,Sebastian Mannweiler,Judith Bosschieter,David Ashabere,Andrea Haitel,Jean François Coté,Soha El Sheikh,Luca Lunelli,Ferran Algaba,Isabel Alemany,Francesco Soria,Willemien Runneboom,Johannes Breyer,Jakko A. Nieuwenhuijzen,Carlos Llorente,Luca Molinaro,Christina A. Hulsbergen-van de Kaa,Matthias Evert,Lambertus A. Kiemeney,James N'Dow,Karin Plass,Otakar Čapoun,Otakar Čapoun,Viktor Soukup,Viktor Soukup,J. Domínguez-Escrig,Daniel Cohen,Daniel Cohen,Joan Palou,Joan Palou,Paolo Gontero,Paolo Gontero,Maximilian Burger,Maximilian Burger,Richard Zigeuner,Richard Zigeuner,Amir Hugh Mostafid,Shahrokh F. Shariat,Shahrokh F. Shariat,Shahrokh F. Shariat,Morgan Rouprêt,Morgan Rouprêt,Eva Compérat,Eva Compérat,Marko Babjuk,Marko Babjuk,Marko Babjuk,Bas W.G. van Rhijn,Bas W.G. van Rhijn +77 more
TL;DR: In this paper, the European Association of Urology (EAU) prognostic factor risk groups for non-muscle-invasive bladder cancer (NMIBC) are used to provide recommendations for patient treatment after transurethral resection of bladder tumor (TURBT).